You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三友醫療(688085.SH):擬與韓國細基生物株式會社共同設立合資公司

格隆匯5月8日丨三友醫療(688085.SH)公佈,三友醫療主要從事骨科植入耗材的研發、生產及銷售的公司。韓國細基生物株式會社是一家集研發、生產及銷售於一體的公司,是韓國領先的醫療器械生物材料製造商和供應商,其研究所是全球唯一同時擁有組織再生時所需的支架、成長因子及細胞治療技術的研究所。CGBIO的五大核心技術分別爲生物陶瓷原料及活性生物骨合成技術、陶瓷/聚合物支架製造技術、人體組織加工技術、植入物設計技術/有限元分析及3D打印技術。雙方有意通過共同設立公司研究和孵化創新細胞生物材料等領域的產品,在中國境內設立具備自主研發和生產能力的生物公司。新設合資公司麗天(太倉)生物科技有限公司,註冊資本人民幣6,000.00萬元,公司認繳註冊資金人民幣3,960.00萬元,韓國細基生物認繳註冊資金人民幣2,040.00萬元。公司持有合資公司66%的股權,韓國細基生物持有合資公司34%的股權。截止目前,公司已完成新設公司的工商註冊登記手續。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account